Enhancing Workflows: Cost Savings, Safety, and Collaboration

Opinion
Video

A panel of experts analyze the impact of prefilled syringes on workflows across diverse patient populations, emphasizing cost savings, patient safety, and interdisciplinary collaboration.

This is a video synopsis/summary of a Practice Pearls featuring Ryan Haumschild, PharmD, MS, MBA, CPEL; Megan Mitchell, PharmD, MS; Stephanie Abel, PharmD, BCPS; and Jennifer Grate, CPhT.

Haumschild leads a discussion on the impact of prefilled syringes, featuring insights from Grate, Mitchell, and Abel. Mitchell highlights the positive influence on nursing workflow for opioid-naive patients, though potential challenges arise for opioid-tolerant patients requiring higher doses. Grate emphasizes the legal risks associated with medication errors, underscoring prefilled syringes' value in preventing adverse events. Abel stresses interdisciplinary collaboration to align dosage forms and clinical practices. Grate advocates for a multidisciplinary approach in product selection, considering frontline feedback. Mitchell acknowledges the need for flexibility, suggesting tailored approaches for units with opioid-tolerant patients. The discussion highlights the nuanced considerations when implementing prefilled syringes, balancing workflow improvements with patient needs in diverse clinical settings.

This summary was AI-generated and reviewed by Pharmacy Times® editorial staff.

Related Videos
Video 14 - "Closing Remarks on RSV Vaccinations"
Video 13 - "Understanding RSV Infection Patterns and Seasonal Outbreaks"
Video 12 - "Empowering RSV Patients: Essential Vaccine Education Resources"
Video 11 - "Unmet Needs in Prevention and Management of RSV"
Video 12 - "Collaborative Care: Key Stakeholders in HE Treatment and Recovery"
Video 11 - "Optimizing Transitions of Care for Hepatic Encephalopathy Patients"
Video 10 - "Valuable Metrics and Improving Adherence in Patients With ASCVD"
Video 9 - "The Role of Pharmacists in Treating Very High-Risk ASCVD"
Video 6 - "evaluating CDK4/6 inhibitor safety profiles"
Video 5 - "CDK4/6 Inhibitor Sequencing and NCCN Guidelines in mBC"
Related Content
© 2024 MJH Life Sciences

All rights reserved.